Retatrutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Few experimental metabolic peptides have generated as much attention as retatrutide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets both the […]

Continue Reading

Cagrilintide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Cagrilintide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects of the […]

Continue Reading

Tirzepatide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Tirzepatide is one of the most important medications to emerge in modern metabolic medicine. It is a once-weekly injectable peptide-based medication that activates two hormone receptors involved in blood sugar control, appetite, and body weight: GIP — glucose-dependent insulinotropic polypeptide and GLP-1 — glucagon-like peptide-1. Because it targets both receptors simultaneously, tirzepatide is commonly described […]

Continue Reading